The Global Non-Oncology Precision Medicine Market is projected to reach around US$ 194.7 Billion by 2034, up from US$ 84.5 Billion in 2024. It is growing at a CAGR of 8.7% from 2025 to 2034. North America currently leads the market, holding over 44.2% share, valued at US$ 37.3 Billion. This growth reflects rising demand for personalized treatments in non-cancer areas. Key segments...